News

Filter

Current filters:

Zolpidem Tartrate

1 to 9 of 161 results

Lunesta misses Ph II efficacy endpoints

16-03-2009

US drugmaker Sepracor's Lunesta (eszopiclone) failed to demonstrate efficacy in a mid-stage trial, assessing…

AmbienAventis PharmaEszopicloneHamiltonLunestaSanofi-AventisZolpidem Tartrate

Survey finds US mail order patients switch to generics

29-09-2008

Two surveys by US pharmacy benefit manager Express Scripts has found that patients who use a home delivery…

AmbienAventis PharmaSanofi-AventisZolpidem Tartrate

Transcept takes over Novacea in all-stock deal

08-09-2008

US drugmaker Novacea plans to merge with privately-held Transcept Pharmaceuticals in an all-stock transaction…

AmbienAmbien CRZolpidem Tartrate

1 to 9 of 161 results

COMPANY SPOTLIGHT

Menarini

Back to top